BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10847483)

  • 1. Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
    Hsieh HF; Harn HJ; Chiu SC; Liu YC; Lui WY; Ho LI
    Liver; 2000 Apr; 20(2):143-51. PubMed ID: 10847483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
    Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
    Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
    Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
    Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
    Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse.
    Kastner A; Moyse E; Bauer S; Jourdan F; Brun G
    J Neurochem; 2000 Jun; 74(6):2343-9. PubMed ID: 10820194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
    Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cyclin D1 and CDK expression in colonic polyps containing neoplastic foci: a study of proteins extracted from paraffin sections.
    Izawa H; Yamamoto H; Ikeda M; Ikeda K; Fukunaga H; Yasui M; Ikenaga M; Sekimoto M; Monden T; Matsuura N; Monden M
    Oncol Rep; 2002; 9(6):1313-8. PubMed ID: 12375040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb and E2F-1 regulate telomerase activity in human cancer cells.
    Crowe DL; Nguyen DC
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.
    Fukumoto S; Koyama H; Hosoi M; Yamakawa K; Tanaka S; Morii H; Nishizawa Y
    Circ Res; 1999 Nov; 85(11):985-91. PubMed ID: 10571528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
    Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
    Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM
    Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
    Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
    Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
    Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
    Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.